FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
17 Maio 2022 - 12:10PM
Dow Jones News
By Will Feuer
The Food and Drug Administration expanded the authorization of
Pfizer Inc.'s Covid-19 booster shot to kids ages 5 through 11 years
old.
While Covid-19 tends to be less severe in kids than in adults,
more kids have been getting sick and hospitalized with the disease
amid the spread of the omicron variant, FDA Commissioner Dr. Robert
Califf said.
"If your child is eligible for the Pfizer-BioNTech Covid-19
Vaccine and has not yet received their primary series, getting them
vaccinated can help protect them from the potentially severe
consequences that can occur, such as hospitalization and death," he
said.
On Jan. 3, the FDA authorized Pfizer and BioNTech SE's Covid-19
booster shot for kids ages 12 through 15.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
May 17, 2022 10:55 ET (14:55 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
